Clinical Trial to Assess the Pharmacokinetic/Pharmacodynamic Characteristics and Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subjects

Trial Profile

Clinical Trial to Assess the Pharmacokinetic/Pharmacodynamic Characteristics and Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Mar 2017

At a glance

  • Drugs CKD 519 (Primary)
  • Indications Dyslipidaemias
  • Focus Pharmacokinetics
  • Sponsors Chong Kun Dang
  • Most Recent Events

    • 19 Jan 2016 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
    • 11 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top